Hikma Pharmaceuticals USA INC.
At a glance
Employees500+
In business since1978
HeadquartersBerkeley Heights, NJ
US patents26
SAM.gov UEINQJ5E87TKNB1
CAGE code32655
Incorporated inDE
- development
- Injectables contract manufacturing
Named on the company’s own website, read JUL 29, 2026
CareersCareers page — seen SEP 8, 2026
Supplier designations
For Profit OrganizationManufacturer of Goods
Self-certified by the company in its SAM.gov registration
Patents
26 US patents granted 2019–2025, 22 of them in the five years to SEP 2025.
Pharmaceuticals 25Handling 1
- Liquid naloxone sprayUS 12,414,915 · granted SEP 16, 2025
- Succinylcholine chloride prefilled syringeUS 12,295,932 · granted MAY 13, 2025
- Phenylephrine hydrochloride ready-to-use solutionUS 12,257,342 · granted MAR 25, 2025
- Liquid composition comprising glucoseUS 12,178,903 · granted DEC 31, 2024
- Glycopeptide compositionsUS 12,161,690 · granted DEC 10, 2024
Newest 5 shown · Granted to Hikma Pharmaceuticals USA Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plants
2 FACILITIES| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Hikma Pharmaceuticals USA INC. | Berkeley Heights | NJ | — | ACTIVE |
| Hikma Pharmaceuticals USA INC. (0125041763) | Columbus | OH | 500+ | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.


